SEC 13F Intelligence

Managers / Q4 2023 · view latest →

Worth Venture Partners, LLC

CIK 0001696778 · 2 EXECUTIVE DRIVE, SUITE 515, FORT LEE, NJ, 07024 · 2125589017

Reported Value
$185M
Q4 2023
Positions
130
Filings on Record
30
2019–present window
Filed
Feb 9, 2024
original filing

Summary

Worth Venture Partners, LLC reported $185M in U.S.-listed holdings across 130 positions for Q4 2023.

Its largest position, Bloomin Brands, represents 4.9% of the portfolio.

Compared with Q3 2023, the fund opened 30 new positions and exited 63.

Portfolio Metrics

Turnover
+25.9%
vs prior filed quarter
Top-10 Concentration
+35.6%
share of reported value
Largest Position
+4.9%
Bloomin Brands
New / Exited
30 / 63
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $132MQ4 ’18Q1 ’19: $180MQ2 ’19: $181MQ3 ’19: $175MQ4 ’19: $204MQ4 ’19Q1 ’20: $162MQ2 ’20: $204MQ3 ’20: $122MQ4 ’20: $126MQ4 ’20Q1 ’21: $206MQ2 ’21: $269MQ3 ’21: $222MQ4 ’21: $202MQ4 ’21Q1 ’22: $217MQ2 ’22: $170MQ3 ’22: $163MQ4 ’22: $169MQ4 ’22Q1 ’23: $205MQ2 ’23: $184MQ3 ’23: $169MQ4 ’23: $185MQ4 ’23Q1 ’24: $15MQ2 ’24: $13MQ3 ’24: $14MQ4 ’24: $10MQ4 ’24Q1 ’25: $53MQ2 ’25: $65MQ3 ’25: $34MQ4 ’25: $14MQ4 ’25Q1 ’26: $32Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 44.5%US DOMESTIC: 40.6%GLOBAL: 7.4%Other: 4.8%REIT: 1.7%Other: 1.0%
  • Common Stock · 44.5% · $82M
  • US DOMESTIC · 40.6% · $75M
  • GLOBAL · 7.4% · $14M
  • Other · 4.8% · $9M
  • REIT · 1.7% · $3M
  • Other · 1.0% · $2M

Quarter-over-Quarter Changes full breakdown →

vs Q3 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ELVAELECTROVAYA INCNEW+820.5K820.5K+$3M$3M
NORTHERN OIL & GAS INCNEW+1.99M1.99M+$2M$2M
TANDEM DIABETES CARE INCNEW+2.03M2.03M+$2M$2M
LPSNUSDLIVEPERSON INCNEW+400.7K400.7K+$2M$2M
PRNPROFOUND MED CORPNEW+161.0K161.0K+$1M$1M
DCTHDELCATH SYS INCNEW+294.2K294.2K+$1M$1M
RCATRED CAT HLDGS INCNEW+1.25M1.25M+$1M$1M
BIOMARIN PHARMACEUTICAL INCNEW+910.0K910.0K+$899,444$899,444

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2023

50 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1BLOOMIN BRANDS INCNOTE 5.000% 5/04.94%$9M3.60M
2LIVENT CORPNOTE 4.125% 7/14.81%$9M4.23M
3ROYAL CARIBBEAN GROUPNOTE 6.000% 8/14.49%$8M3.12M
4MYOMYOMO INChistory →COM NEW3.78%$7M1.40M
5ASPNASPEN AEROGELS INChistory →COM3.76%$7M441.0K
6CHART INDS INCNOTE 1.000%11/13.26%$6M2.57M
7PROGRESS SOFTWARE CORPNOTE 1.000% 4/13.01%$6M5.26M
8SCPHSCPHARMACEUTICALS INChistory →COM2.61%$5M771.3K
9INDIINDIE SEMICONDUCTOR INChistory →CLASS A COM2.46%$5M560.4K
10VERADIGM INCNOTE 0.875% 1/02.43%$4M4.45M
11TGANTRANSPHORM INChistory →COM2.28%$4M1.15M
12TRANSOCEAN INCDEB 4.625% 9/32.17%$4M1.92M
13SAREPTA THERAPEUTICS INCDBCV 1.500%11/12.14%$4M2.79M
14OUSTOUSTER INChistory →COM NEW1.95%$4M469.3K
15GEO CORRECTIONS HOLDINGS INCNOTE 6.500% 2/21.93%$4M2.55M
16PATRICK INDS INCNOTE 1.750%12/01.84%$3M2.98M
17VAREX IMAGING CORPNOTE 4.000% 6/01.65%$3M2.55M
18STARWOOD PPTY TR INCNOTE 6.750% 7/11.50%$3M2.55M
19COFCAPITAL ONE FINL CORPhistory →COM1.47%$3M20.7K
20CINEMARK HLDGS INCNOTE 4.500% 8/11.46%$3M2.23M
21HGVHILTON GRAND VACATIONS INChistory →COM1.43%$3M66.0K
22ELVAELECTROVAYA INChistory →COM NEW1.36%$3M820.5K
23ALIMERA SCIENCES INCCOM NEW1.30%$2M556.6K
24OMFONEMAIN HLDGS INChistory →COM1.29%$2M48.4K
25NORTHERN OIL & GAS INCNOTE 3.625% 4/11.27%$2M1.99M
26TELATELA BIO INChistory →COM1.24%$2M345.3K
27PGRPROGRESSIVE CORPhistory →COM1.22%$2M14.1K
28ZIFF DAVIS INCNOTE 1.750%11/01.18%$2M2.30M
29MARRIOTT VACATIONS WORLDWIDENOTE 1/11.15%$2M2.41M
30BIODESIX INCCOM1.14%$2M1.14M
31POST HLDGS INCNOTE 2.500% 8/11.11%$2M2.03M
32NUVASIVE INCNOTE 0.375% 3/11.08%$2M2.13M
33TANDEM DIABETES CARE INCNOTE 1.500% 5/01.04%$2M2.03M
34CELLECTAR BIOSCIENCES INCCOM NEW1.04%$2M693.9K
35APOAPOLLO GLOBAL MGMT INChistory →COM1.01%$2M20.0K
36IRONWOOD PHARMACEUTICALS INCNOTE 0.750% 6/10.94%$2M1.64M
37BWAYBRAINSWAY LTDSPONSORED ADS0.91%$2M258.5K
38FRXFENNEC PHARMACEUTICALS INCCOM0.86%$2M141.5K
39EXPEDIA GROUP INCNOTE 2/10.85%$2M1.65M
40MICROSTRATEGY INCNOTE 0.750%12/10.85%$2M944.0K
41PARSONS CORP DELNOTE 0.250% 8/10.84%$2M1.09M
42SPRUCE BIOSCIENCES INCCOM0.83%$2M526.9K
43LPSNUSDLIVEPERSON INCCOM0.82%$2M400.7K
44BACBANK AMERICA CORPCOM0.81%$2M44.7K
45FCFRANKLIN COVEY COCOM0.81%$1M34.4K
46INTEGRA LIFESCIENCES HLDGS CNOTE 0.500% 8/10.79%$1M1.56M
47TQ80THERATECHNOLOGIES INCCOM NEW0.79%$1M906.6K
48ITIEURITERIS INC NEWCOM0.78%$1M278.8K
49RJFRAYMOND JAMES FINL INCCOM0.76%$1M12.7K
50APLTAPPLIED THERAPEUTICS INCCOM0.75%$1M413.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$32M55May 14, 202613F-HRchanges · EDGAR ↗
Q4 2025$14M53Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$34M64Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$65M42Aug 13, 202513F-HRchanges · EDGAR ↗
Q1 2025$53M36May 14, 202513F-HRchanges · EDGAR ↗
Q4 2024$10M34Feb 12, 202513F-HRchanges · EDGAR ↗
Q3 2024$14M49Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$13M56Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$15M63May 13, 202413F-HRchanges · EDGAR ↗
Q4 2023$185M130Feb 9, 202413F-HRchanges · EDGAR ↗
Q3 2023$169M163Nov 15, 202313F-HRchanges · EDGAR ↗
Q2 2023$184M173Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$205M194May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$169M183Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$163M183Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$170M150Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$217M148May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$202M130Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$222M130Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$269M115Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$206M111May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$126M101Feb 17, 202113F-HRchanges · EDGAR ↗
Q3 2020$122M220Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$204M220Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$162M198May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$204M178Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$175M193Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$181M197Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$180M204May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$132M209Feb 15, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 3 additional managers.

  • DLD ASSET MANAGEMENT, LP
  • AIGH CAPITAL MANAGEMENT, LLC
  • PB INVESTMENT PARTNERS, L.P.

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.